Cochrane Abstracts
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cannabis and Cannabinoids for Symptomatic Treatment for People With Multiple Sclerosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435946/all/Cannabis_and_cannabinoids_for_symptomatic_treatment_for_people_with_multiple_sclerosis.
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435946/all/Cannabis_and_cannabinoids_for_symptomatic_treatment_for_people_with_multiple_sclerosis. Accessed February 11, 2026.
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435946/all/Cannabis_and_cannabinoids_for_symptomatic_treatment_for_people_with_multiple_sclerosis
Cannabis and Cannabinoids for Symptomatic Treatment for People With Multiple Sclerosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435946/all/Cannabis_and_cannabinoids_for_symptomatic_treatment_for_people_with_multiple_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis
ID - 435946
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435946/all/Cannabis_and_cannabinoids_for_symptomatic_treatment_for_people_with_multiple_sclerosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
